As drug development becomes more complex, so do the demands for accurate, reproducible bioanalytical data to prove their ...

This training session presents opportunities in enhancing compliance and efficiency in drug manufacturing by deepening understanding of FDA and EU guidelines, emphasizing product lifecycle alignment, ...

Key market opportunities in dissolution testing include optimizing drug bioavailability and enhancing quality control to meet regulatory demands. Understanding scientific principles and regulatory ...

AI refers to a machine-based system and ML refers to a set of techniques that can be used to train AI algorithms (2) so ML should not be considered outside the scope of AI.

Optimizing icIEF identifies mAbs more accurately, while staying within European Pharmacopoeia and ICH guidelines.

Dr. Yuan will be moderating the symposium, “Oligo Bioanalysis, Platforms and Methods” on Wednesday, Nov. 12, 2025 at 9AM in ...

In this GEN webinar, our expert speakers will share emerging methods and strategies in virus production and characterization that help manufacturers align with regulatory expectations ...

The U.S. IND CDMO market offers growth via extensive pipelines in oncology and rare diseases, driven by technological advancements, outsourcing trends, regulatory efficiencies, and modular GMP ...

Veloxity Labs, a bioanalytical CRO built for programs that need speed with purpose, today announced the acquisition of the ZenoTOF 8600 system from SCIEX, a global leader in life science analytical ...

The medical device industry has gone global, but most quality and regulatory leaders still operate with regional mindsets. Leaders who master cultural intelligence build quality systems that leverage ...